骨关节炎研究的最近目标
Po-Cheng Shih1, Yung-Heng Lee2, Hsi-Kai Tsou3
1Department of Allergy, Immunology & Rheumatology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Best practice & research. Clinical rheumatology
|July 8, 2023
概括
确定可靠的骨关节炎生物标志物对于早期诊断和有效治疗至关重要. 对图像和生物化学标记物的研究,如RNA和细胞因子,为疾病的发病提供了新的见解.
科学领域:
- 生物医学研究的研究.
- 分子生物学分子生物学
- 临床诊断 临床诊断 临床诊断
背景情况:
- 骨关节炎 (OA) 是一种普遍存在的退行性关节疾病,对全球健康产生重大影响.
- 目前的OA诊断依赖于临床症状和成像,缺乏早期和精确的指标.
- 对可靠的生物标志物的需求对于改善早期检测,监测疾病进展和指导治疗策略至关重要.
研究的目的:
- 审查骨关节炎生物标志物的演变.
- 突出病原发生在生物标志物发现中的作用.
- 强调持续研究对更好的OA管理的重要性.
主要方法:
- 关于骨关节炎生物标志物的文献综述.
- 图像模式和生物化学标记物的分析.
- 探索生物标记物,包括原降解产物,细胞因子,微RNA,长非编码RNA和循环RNA.
主要成果:
- 已经确定了几类骨关节炎的生物标志物.
- 生物标记物包括成像技术和各种生物化学分子.
- 这些标志物为OA病原体提供了新的见解.
结论:
- 生物标志物对于促进骨关节炎的诊断和治疗至关重要.
- 对新型生物标志物的持续研究对于改善患者的治疗结果至关重要.
- 了解骨关节炎的发病是制定有效的基于生物标志物的策略的关键.
相关概念视频
Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K
Osteoclasts in Bone Remodeling
3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K
Targets for Drug Action: Overview
6.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.4K


